Hongene Biotech
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
29520 Kohoutek Way, Union City, Californ...Phone Number
(510) 931-4711Website
www.hongene.comRevenue
$6.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Hongene Biotech
Hongene Biotech Corporation specializes in oligonucleotide CDMO services, offering advanced synthesis and manufacturing solutions with a focus on RNA therapeutics. With nearly 30 years of expertise, the company provides a vertically-integrated platform that simplifies supply chains and accelerates product timelines while ensuring high quality. Their extensive product portfolio includes raw materials for mRNA synthesis, diagnostics, and custom synthesis services. Hongene aims to make RNA medicines accessible and affordable, supporting clients in the biotech industry with innovative and sustainable manufacturing practices.Explore more
Hongene Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hongene Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Hongene Biotech has new funding data
Check if Hongene Biotech has recently received funding, and reach out quickly before it becomes old news!
Check out if Hongene Biotech is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Hongene Biotech launches new products
Earning: See what the market has to say on Hongene Biotech recently announced quarterly report
Click to see if Hongene Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Hongene Biotech
Website visits: Recent activity has been detected on your website
Hongene Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Hongene Biotech
Find 3 more new buyers
Compare Similar Companies to Hongene Biotech
Compare insights from companies similar to Hongene Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hongene Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hongene Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hongene Biotech.
Hongene Biotech Tech Stack
A closer look at the technologies used by Hongene Biotech
Hongene Biotech News & Media
Hongene Biotech Seeks Pre-IPO Funds at $6 Billion Value
(Bloomberg) -- Hongene Biotech Corp. is weighing a new funding round that could value the Chinese synthesis blocks and enzymes maker at about $6 billion, people familiar with the matter said.Most Read from BloombergStriking Drop in Stress Hormone Predicts Long Covid in StudyChina Has Painted Itself Into a Semiconductor CornerThe Fed’s Damage to the Housing Market May Last YearsDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsMedia Tallies Show Extremely Tight Presidency Race:
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hongene Biotech
Sign Up For FreeTo access detailed company insights
Hongene Biotech Corporation specializes in oligonucleotide CDMO services, offering advanced synthesis and manufacturing solutions with a focus on RNA therapeutics. With nearly 30 years of expertise, the company provides a vertically-integrated platform that simplifies supply chains and accelerates product timelines while ensuring high quality. Thei... Read More
